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I. INTRODUCTION 
 
 
The name quinazoline (German: Chinazolin) was first proposed for this 
compound by Weddige, on observing that this was isomeric with the compounds 
cinnoline and quinoxaline. Paal and Bush suggested the numbering of quinazoline 
ring system, which is currently used. The other less commonly used names for this 
ring system are ‘phenmiazine’ and 5,6-benzopyrimidine. 
 
Of many derivatives of quinazoline system known so far, keto-quinazolines 
also called as quinazolinones, are the most important compounds. Depending upon 
the position of the keto or oxo group, these compounds may be classified into two 
types: 2-(1H) quinazolinones (or) 1, 2-dihydro-2-oxo quinazolines and 4(3H)- 
quinazolines or 3, 4-dihydro-oxoquinazolines. These systems exhibit lactam-lactim 
tautomerism and undergo hydroxyl group replacement reactions. 2-Cyano-4(3H)- 
quinazolinone was the first quinazolinone derivative to be synthesized. 
 
Reactivity of 4(3H)-Quinazolinones 
 
 
Reactions associated with tautomeric nature of the quinazolinones are often 
quite complex and generally unpredictable. The recorded chemical investigation on 
the subject is voluminous. The amide linkages in quinazolinones should not be looked 
on  as  predominantly the  keto  or  the  enol  form  but  as  true  keto-enol  tautomers, 
showing reaction characteristic of both the forms. 
 
Quinazolinones are always high melting crystalline solids, insoluble in water 
and  in  most  organic  solvents  but  soluble  in  aqueous  alkali.  They  are  generally 
insoluble in dilute acids but are sometimes soluble in concentrated acids. Simple 
4(3H)-quinazolinones,   although   insoluble   in   dilute   acids,   are   soluble   in   6N 
 
hydrochloric    acid.    4(3H)-quinazolinones    form    stable    monohydrochlorides, 
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chloroplatinate, chloroaurates and picrates and their metal salts of silver, mercury, 
zinc, copper, sodium and potassium. 
 
Stability of the ring system 
 
 
The ring system in quinazolinone is exceedingly stable in oxidation, reduction, 
hydrolysis reactions and other treatment designed to break the ring. There is no report 
of degradation of quinazolinone by simple chemical oxidation. 
 
Biological importance of 4(3H)-Quinazolinones 
 
 
The quinazolinone skeleton is a frequently encountered heterocycle in 
medicinal  chemistry literature  with  applications  including  antibacterial,  analgesic, 
antiinflammatory, antifungal, antimalarial, antihypertensive, CNS depressant, 
anticonvulsant, antihistaminic, local anaesthetic, antiparkinsonism, antiviral and 
anticancer activities. Little number of quinazolinones was reported as potent 
chemotherapeutic agents in the treatment of tuberculosis. For example 3-aryl-6, 8- 
dichloro-2H-1,3-benzoxazin-2,4(3H)-diones   and   3-arylquinazolin-2,4(1H,3H)- 
diones as   antimycobacterial   agents,   quinazolinone   derivatives as   antitubercular 
agents. (Dr. S. N. Meyyanathan, Pharmainfo.net., 2005). 
 
Research programs for the discovery of new antimicrobial drug for improving 
the evaluation criteria are under way in many laboratories.  In addition, knowledge of 
specific constituents of the mycobacterial cell and their biochemical role has advances 
considerably in the recent years and may permit a more rational approach to the 
design of new drug acting on specific targets.   Also recent improvements in the 
knowledge of the mechanism  of action  of the available drug in  the biochemical 
mechanism of resistance to them may be used as a basis for designing new and better 
weapons to fight the mycobacterial diseases. 
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The quinazolines and quinazolones when selectively functionalized act as 
building blocks for the preparation of numerous biological active compounds.   The 
quinazolines are found to exhibit antifungal, antitubercular, antitumour and 
anticonvulsant activities.  (Shahikant R Pattan., et al., 2006). 
 
The   need   of   new   antimicrobial   agents   is   justified   because   more 
microorganisms are being resistance to the present drugs available in the market. 
Worldwide  researchers  are  trying  to  synthesize  new  drugs  with  better 
pharmacokinetic  and  dynamic  properties  with  less  adverse  effects.  The  literature 
survey suggests that the 2, 3-substituted quinazolin-4-ones have proved to be the good 
bioactive molecules. They have shown diverse biological activities like antibacterial, 
antifungal, antiinflammatory, antitubercular, anticonvulsant, antiHIV, cardiac 
stimulant, diuretic and anticancer activity etc. (Jayshari S Pattan., et al., 2009). 
Pharmacologically, quinazolin-4-ones are most important classes of 
heterocyclic compounds. These compounds possess versatile type of biological 
activities. Structure activity relationship studies of quinazolinone ring system revealed 
in various literatures suggest that position 2, 6 and 8 are very much important for 
structure activity studies. ( Raghavendra N.M., et al., 2008). 
The exploitation of a simple molecule with different functionalities for the 
synthesis   of   heterocyclic   is   a   worthwhile   contribution   in   the   chemistry   of 
heterocycles. Quinazolones have been frequently used in medicine because of their 
wide spectrum of biological activities. In light of the growing number of applications 
in recent years, there has been an enormous increase in the interest among biologists 
and chemists in their synthesis and bioactivity of quinazoline derivatives. 
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Analgesics are the drug which relieves pain without disturbing consciousness. 
Pain is an unpleasant sensory and emotional experience associated with actual or 
potential tissue damage. Pain acts as a warning signal against disturbances either in 
the body or in the external environment of an individual and thus has protective 
function. (Gupta S. K ., 2004) 
Analgesics are classified into opioid and Non opioid analgesics. The term 
opioid is used to denote all naturally occurring, semisynthetic and synthetic drugs, 
which have morphine like action. These drugs are called Narcotic analgesics. e.g. 
morphine and their derivatives, codeine and its derivatives, synthetic compounds such 
as Pethidine, Methadone, Propoxyphene, Levorphanol and Tramadol. 
Opioid drugs produce their effects by binding to opioid receptors, which are 
widely distributed in CNS and other tissues. Opioid receptors are also present in the 
peripheral nerves where they probably respond to peripherally applied opioids and 
locally released endogenous peptides during inflammation. 
Non opioid analgesics are the agents which do not interact with opioid 
receptors and relieve pain without depressing the CNS. e.g. Salicylates and related 
compounds.  Efforts towards the development and identification of new molecules for 
analgesic and antiinflammatory activities with minimal gastrointestinal ulceration side 
effects have gained lot of significance. There are no promising quinazolines which are 
in the market in these NSAIDS category except few drugs like Proquazone, 
Afloqualone and Diproqualone etc. 
 
The novel derivatives of quinazolines mentioned might be beneficial in terms 
of biological activity for which further studies can be done to confirm it as a potential 
drug  candidate.  Proquazone  a  derivative  of  quinazolin-4-one  exhibits  potential 
NSAID  which  has  been  used  in  the  disease  conditions  like  rheumatoid  arthritis, 
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ankylosing spondylitis, osteoarthritis, inflammatory conditions and acute pain states 
such as dysmenorrhea, postoperative pain and headache. Its derivative fluproquazonal 
has potent analgesic action. (Vijaychand et al., 2011) 
 
Bacteria are microorganisms that have circular double-stranded DNA and 
(except for mycoplasmas) cell walls. Most bacteria live extracellularly. Some bacteria 
eg. Salmonella typhi, Neisseria gonorrhoeae, Legionella, Mycobacterium, Chlamydia, 
and Chlamydophila spp  preferentially  residue  and  replicate  intracellularly.  Some 
bacteria such as chlamydiae and rickettsiae are obligate intracellular pathogens (i.e., 
able to grow, reproduce, and cause disease only within the cells of the host). Others 
(eg, Salmonella     typhi, Brucella sp, Francisella     tularensis, N.     gonorrhoeae, N. 
meningitidis, Legionella and Listeria spp, Mycobacterium tuberculosis) are facultative 
intracellular pathogens. 
Antibacterial drugs are derived from bacteria or molds are synthesized by de 
novo.  Technically, antibiotic refers only to antimicrobials derived from bacteria or 
molds but is often including used synonymously with antibacterial drug. 
Antibiotics have many mechanisms of action, including inhibiting cell wall 
synthesis, activating enzymes that destroy the cell wall, increasing cell membrane 
permeability and interfering with protein synthesis and nucleic acid metabolism. 
Antibiotics sometimes interact with other drugs. Raising or lowering serum 
levels of other drugs by increasing or decreasing their metabolism or by various 
other mechanisms. 
 
The rapid rise in bacterial resistance to the traditional antibiotics such as penicillins 
and  tertracyclines  has  encouraged  a  continuing  search  for  new  classes  of 
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compounds with novel modes of antibacterial activity. 
 
 
 
In view of the above reports, the design and synthesis of newer 
antimicrobials is an area of immense significance and continues to attract the 
attention of increasing number of medicinal chemists. 
 
With  the  interest  of  on  quinazolin-4-ones  due  to  its  extension 
pharmacological  actions  we  have  designed  a  new  series  of  quinazolinone 
substituted at 2
nd  
position with chloromethyl and 3
rd  
position with different amino 
acid and heterocycles. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
OBJECTIVE OF THE 
 
WORK 
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II. OBJECTIVES OF THE WORK 
 
 
 
 To synthesize 2-chloromethyl-3-amino acid substituted quinazolin-4(3H)-one. 
 
 To synthesize different 2-chloromethyl-3-heterocyclic substituted Quinazolones 
by cyclizing the chloroacetyl anthranilic acid with amino substituted indole, 
benzthiazole and pyridine. 
To characterize the structures of the synthesized compounds by various 
spectroscopic methods via IR, NMR and Mass spectroscopy. 
 To screen the analgesic activity of synthesized compounds by Eddy’s hot plate 
 
method. 
 
 To  evaluate  the  antimicrobial  activity  of  synthesized  compounds  by  Disc 
 
Diffusion method. 
 
 To interpret and conclude the results obtained from the study. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LITeRATURE 
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III. LITERATURE REVIEW 
 
 
 
Rajitha G. et al., (2011) synthesized some novel 3-[5-phenyl-1,3,4-oxadiazol- 2-yl]- 
 
2-(substituted styryl)-quinazolin-4(3H)-ones and evaluated for antibacterial activity. 
 
O  N   N 
N 
O 
 
 
 
C6H5 
N 
 
R 
 
 
 
R = H, OCH3, CH (CH) 3, Cl, N (CH3)2, NO2, CH3 
 
 
Narendra babu et al., (2011) carried out the synthesis of new quinazolinone and the 
compounds were screened for antiinflammatory and anthelmintic activities. 
 
O  N 
O N 
N                         C   NH N  C 
Ar2 
 
 
Ar1 
 
N 
 
 
 
 
Ar1 = NO2 N(CH3)2 
 
 
 
 
 
 
 
 
 
Ar2 =                       Br Cl                            C2H5 
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Ponnilavarasan Ilangovan et al., (2010) synthesized a series of different 
quinazolinone derivatives, and they were examined by invitro studies for 
anticonvulsant and antimicrobial activities. 
 
O 
X                       
N  NH    C 
 
R1 
NH   N    C 
R2
 
O 
N       R 
 
X 
 
 
OH 
 
R = 
OH 
 
 
 
 
O 
 
O 
R1 , R2 =                              
O 
N 
H 
 
Mariappan G. et al., (2010) synthesized a series of some unique quinazolone fused 
 
schiff bases  and those compounds were evaluated for  biological activity. 
 
 
 
H        Ar 
O 
 
NH 
N 
 
 
N 
 
 
 
 
 
 
 
 
Ar =                                                   O 
O                                                                 
O 
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C 
 
 
 
Beena K. P. et al., (2010) synthesized new series of quinazolinone derivatives 
 
for antibacterial activity. 
 
O 
 
N          N     CH   R 
 
 
O 
N        
6
H
5 
CH
2
Cl 
 
CH3 
 
 
R = CH3 CH3 
OCH3 
 
 
 
Kale A. U. et al., (2010) synthesized some new 2, 3-disubstituted quinazolin-4-(3H)- 
 
ones and they were tested for invitro antimicrobial activity. 
 
 
O 
 
R 
N 
 
 
N 
 
 
 
 
 
 
 
 
R =                             NH2  F    NH 
 
 
H2N 
NH2 
 
 
 
S 
 
 
 
 
 
 
H2N 
NH2 
 
 
 
O 
 
 
H2N 
 
O 
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Rajveer C. H. et al., (2010) carried out the synthesis of 2-(6-bromo-2-phenyl-4- 
oxoquinazolin-3(4H)-yl)-N-substituted acetamides and 1-amino-5-(6-bromo-3, 4- 
dihydro-2-phenyl-4-oxoquinazolin-3yl) methly-1,3,4-triazin-2-thiol and the selected 
compounds were  examined for  antimicrobial activity. 
 
 
 
 
O 
 
Br 
N      CH2  CO   NH  R 
 
N 
 
 
 
 
 
 
 
R =                                                       NO2                                  Cl 
 
 
 
 
 
 
CH3                               OCH3 
 
 
 
 
Dubey et al., (2010) synthesized a novel series of 2-(4-substituted sulfonyl piperazin- 
 
1-ylmethyl-3-aryl-quinazolin-4(3H)-one and screened for the antimicrobial activity. 
 
 
O                                  
O 
 
N  N   
S     
R 
N  O 
N 
 
 
 
 
R = CH3, C2H5, C3H7 
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Shashikant R. Pattan et al., (2009) synthesized some new quinazolone derivatives 
and the proposed compounds were screened for antimicrobial, antifungal, antitubercular 
and antiinflammatory activities. 
 
 
 
O 
N    N 
 
N 
S 
 
N 
 
HN     R 
 
 
 
N   N 
N 
N 
R =                                  SO2NH2 
H2NOC                                   N 
N                        H 
 
COOH 
 
 
 
 
Narsaiah B. et al., (2009) carried out the synthesis of novel 2, 4, 6 trisubstituted 
quinazoline derivatives showing antibacterial and cytotoxic activities against THP-1, 
HL-60 and A375 cell line. 
 
HN                                   
CH3 
X                                                  n 
N 
 
N       R 
 
 
 
X = H, Br, I 
 
R = CH3, CF3, C6H5, C6H4F3 
 
 
 
Vijayanand R. et al., (2009) synthesized a series of 4-oxo-2-phenyl-4H quinazolin-3- 
carboxylic   acid   (4-substituted   phenyl   amides)   by   condensing   2-phenyl-3,   1- 
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benzoxazin-4one and 4-substiuted phenyl urea. The compounds were found to have 
 
significant effect against bacterial and fungal organisms. 
 
 
 
 
R 
O          O 
 
N          NH 
 
 
N 
 
 
 
 
R = Cl, Br, NO2, SO2NH2, COOH 
 
Salahuddin M. D. et al., (2009) synthesized some novel 3-(6-Substituted-1, 3- 
benzothiazol-2-yl)-2-[{(4-substituted phenyl) amino} methyl} quinazolin-4(3H)-ones 
with various substituted amine and selected derivatives are investigated for 
antiinflammatory and antibacterial activities. 
 
 
N 
O                                            R 
 
N           S 
 
N      CH2NH                         R1 
 
 
R = CH3, OCH3, Cl, F 
 
R1 = H, CH3, OCH3, Cl, 
 
 
 
Gowramma B. et al., (2009) synthesized few compounds of 1-sustituted phenyl 2- 
[(bis-(2-chloroethyl)amino]-methyl-7-nitro-4(1H)-quinazolinone by chlorination with 
phosphorous oxychloride and phosphorous penta chloride and all the compounds were 
incorporated with nitrogen mustard moiety and screened for anticancer activity. 
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O 
 
 
 
 
O2N 
N 
 
 
N       CH2   N 
 
 
R 
 
 
CH2 
 
CH2 
 
 
CH2    Cl 
 
CH2    Cl 
 
 
 
 
R = OCH3, OC2H5, ONO2, -H, -CH3, -N(CH3)2. 
 
 
 
Avinsah patil et al., (2009) carried out a new synthesis of 2-[{5-substituted-1H- 
benzimidazol-2-yl sulfinyl} methyl]-3-substituted Phenyl Quinazolin-4(3H)-one 
derivatives; antiulcer activity of the derivatives were studied by pylorous ligation 
induced ulcer models in rats. 
 
 
 
R 
 
O 
 
N 
O 
 
N       CH2     S 
H 
 
N                   R1 
 
N 
H 
 
 
 
 
R = H, CH3, OC2H5,   Br, Cl 
 
R1= H, OCH3, OCH2F 
 
 
Jai singh  et  al.,  (2008) synthesized  an  innovative  series  of 2-{5ʹ-(4-Pyridinyl)- 
 
1ʹ,2ʹ,3ʹ-oxadiazol-2-yl-thiomethyl]-3-substituted-aryl-6-substituted-quinazolin-4- 
one and all the compounds were screened for antiinflammatory activity. 
Synthesis of quinazolinones LITERATURE REVIEW 
Adhiparasakthi College of Pharmacy Page 15 
 
 
 
 
 
R 
 
O 
 
 
X                                                   N   N 
 
N CH2    S                                   N 
O 
 
 
 
X = H, Br, I 
 
R = H, Cl, OCH3, 
 
Raghavendra M. N. et al., (2008) synthesized by condensation of 2-chloro-N-(4-oxo- 
substituted-quinazolin-3(4H)-yl)-acetamides with various substituted piperazines 
through single step reaction and the derivatives were investigated for antibacterial and 
antifungal activities. 
 
O 
X 
N    NHCOCH2 
 
 
 
N          NH 
 
N       R 
 
X = H, Br 
 
 
 
 
 
R = CH2, CH2-CH2-CH3, 
 
 
 
 
 
Suthakaran  R.  et  al.,  (2008) synthesized  a  different  sequence  of 3-(2-(4)-4- 
substituted benzylidene-4, 5-dihydro-5-oxo-2-phenyl imidazol-1-yl) ethyl)-6, 8- 
un/dibromo subtituted-2-substituted quinazolin-(3H)-one and compounds were 
investigated for antibacterial and antifungal activities 
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R1 
 
 
O                     O 
N 
X 
N  CH2   CH2     N 
 
N     R 
X 
 
X = H, Br 
 
R = CH3, CH2Cl, C6H5 
 
R1 = OH, Cl 
 
 
Srinivasa reddy et al., (2007) synthesized a series of 1-phenyl-2-(substituted)-4-(1H) 
quinazolinones and the compounds were screened for in vivo analgesic and 
antiinflammatory activities. 
 
 
O 
 
 
NH 
N CH2R 
CONH2 
 
 
 
 
 
 
 
 
 
 
CH3 
 
 
R =            NH NH                   COCH3 
 
 
 
 
 
 
N                      N          O NHNH 
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Jessy E. M. et al., (2007) synthesized a unique series of 2, 3-disubstituted-3, 1- 
quinazolin-4-(3H)  ones  and  the  compounds  were  screened  for  antibacterial  and 
antiinflammatory activities. 
 
 
 
R    R1 
 
O                           R2 
 
N       
R
 
4  
R3 
N       CH  CH                   R5 
 
 
 
 
R = R1 = H, COOH 
R2 = H, Br 
R3 = R4 = H, Cl 
 
R5 = NO2, OCH3, OH 
 
 
Ashis Kumar Nanda et al., (2007) synthesized of ten 3-(arylidene amino)-2- 
phenylquinazolin-4(3H)-ones with QSAR studies are carried out and the compounds 
were investigated for antimicrobial activity. 
 
 
 
O                                               R 
 
N    N     CH 
 
 
N 
 
 
 
 
 
 
 
 
R = CH3, OH, F, Cl, NO2. 
CH3 
Synthesis of quinazolinones LITERATURE REVIEW 
Adhiparasakthi College of Pharmacy Page 18 
 
 
 
 
 
Shashikant  R.  Pattan  et  al.,  (2006)  synthesized  a  new  series  of  N-3[(4-(4- 
chlorophenyl  thiazole-2-yl)-(2-(amino)  methyl)-quinazolin-4(3H)-ones  and  all  the 
derivatives were screened for their antitubercular activity. 
 
 
 
 
 
O             
N                                 Cl 
N 
S 
N          CH2  NH     R 
 
 
 
 
 
 
R =                                   CH3    N          N COOH 
 
 
 
 
 
 
 
Tripti  singh  et  al.,  (2006)  synthesized  a  series  of  heterocyclic  derivatives  of 
quinazolinone and the compounds were screened for insecticidal and antimicrobial 
activities. 
 
 
 
O 
N 
 
I                       N   
N
 
 
CH2     CH2     NH   R 
N 
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N 
 
R =                                                     N 
H                     N 
S 
 
 
N 
N   N 
 
H2C 
N                                             O 
 
 
 
Mistry D. et al., (2006) synthesized of newer quinazolinones and the compounds 
 
were screened for antimicrobial activity. 
 
 
 
 
O 
Br 
N      N     C 
 
N       N                            R 
N       CH3 
 
R = H, OCH3,  Br, Cl, NO2, 
 
 
Manish Patel et al., (2005) carried out the synthesis of new 2, 3, 6-trisubstituted 
quinazolin-4(3H)-ones and antibacterial potential was evaluated for the selective 
moieties. 
 
 
 
 
 
N 
R3                                   O                                              R1 
NH 
N            S 
 
R2                     COOH         
N       R
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R = CH3 
 
 
 
R1 = OCH3 
 
R2 = R3 = H, Br 
Pandey D. et al., (2005) synthesized a new series of isoquinolinyl quinazolones and 
investigated all the compounds for  antiviral and antifungal activities. 
 
O 
 
 
N 
 
N       R 
H5C6 
O 
N 
 
C6H5 
 
 
 
N   N 
 
S      
R1 
 
 
 
 
 
R = CH3, C2H5, C5H5-CH=CH, 
NO2                                  Cl 
 
R1 = CH3, C2H5 
 
 
 
Ashok kumar et al., (2003) synthesized some new 2, 3, 6 trisubstituted quinazolinone 
for potent antiinflammatory, analgesic and COX-2 inhibitory activities. 
R1 
O        NH 
Br 
N 
 
N       CH2COCH2NHN=CH  -R 
 
 
 
 
R= H, CH3, OCH3 
 
R1 = CH3, C2H5, C6H5, Br, Cl 
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Bhatta V. et al., (1998) synthesized new sequences of 3-aryl-2-(4ʹ-aryl thiazol-2ʹ- 
yl aminomethyl quinazolin-4(3H)-ones and all the compounds were investigated for 
antimicrobial activity. 
 
 
 
 
O              R1 
Br 
N 
 
N        CH2       N                               R2 
HN 
S 
 
R1 = H, CH3, OCH3, Cl 
 
R2 = CH3, OCH3, Cl 
 
 
 
Surendara bahadur et al., (1982) synthesized of some newer-4(3H)-quinazolinones 
and the compounds were examined  for antimicrobial agents. 
 
O 
R1 
N                             R3 
 
N        S      CH2  CONH                          O                              
R 
R2 
 
R = H, CH3 
 
R1 = R2 = H, Br 
 
 
 
R3 = H, CH3, OCH3, Cl 
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IV. EXPERIMENTAL SECTION 
 
 
 
A.  MATERIALS AND METHODS 
 
 
List of chemicals and instruments used for the study: 
 
 
Table-1 
 
S. No   Chemicals / Instruments Supplier / Model 
Chemicals 
1. Alanine Spectrochem Pvt. Ltd., 
2. Glycine Lobachem Pvt. Ltd., 
3. Leucine Spectrochem Pvt. Ltd., 
4. Phenyl alanine Lobachem Pvt. Ltd., 
5. Anthranilic acid Sigma Aldrich 
6. Chloroacetyl chloride Lobachem Pvt. Ltd., 
7. Benzene Lobachem Pvt. Ltd., 
8. Hydrazine hydrate Lobachem Pvt. Ltd., 
9. Ethanol Lobachem Pvt. Ltd., 
10. Acetone Lobachem Pvt. Ltd., 
11. Pyridine Lobachem Pvt. Ltd., 
12. Benzimidazole Lobachem Pvt. Ltd., 
13. Glacial acetic acid Spectrochem Pvt. Ltd., 
14. t-butyl oxy carbonic anhydride Qualigens Fine Chemicals 
15. Iso propyl alcohol Lobachem Pvt. Ltd., 
16. Chloroform Spectrochem Pvt. Ltd., 
17. Petroleum ether (40-60
0
c) Qualigens Fine Chemicals 
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18. Thionyl chloride Spectrochem Pvt. Ltd., 
19. Sodium hydroxide Spectrochem Pvt. Ltd., 
20. Methanol Qualigens fine Chemicals 
21. Dichloro methane Lobachem Pvt. Ltd., 
22. Tetrahydro furan Lobachem Pvt. Ltd., 
23. Trifluroacetic acid Qualigens Fine Chemicals 
24. Sodium sulphate anhydrous Qualigens Fine Chemicals 
25. Conc. sulphuric acid Lobachem Pvt. Ltd., 
26. Conc. hydrochloric acid Qualigens Chemicals 
27. Diethyl ether Qualigens Fine Chemicals 
Instruments 
28. Magnetic stirrer Remi Equipments 
29. Weighing balance Shzimadzhu 220 v 
30. Melting point apparatus Sun bim Equipments 
31. Hot air oven Picses Instruments 
32. Heating mantle Ajay Equipments 
 
 
 
Methods 
 
 Melting  points  were  determined  by  using  open  capillary  tubes  and  were 
uncorrected. 
 
 The completion of reaction and purity of the compounds were checked by thin 
layer chromatography on pre-coated silica gel plates using iodine vapours as 
detecting agent. 
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   The I.R spectra of the synthesized compounds were recorded in JASCO FT-IR 
 
spectrophotometer in Ideal Analytical Lab, Puducherry. 
 
 
   The NMR spectra of the synthesized compounds were recorded in BRUKER 
 
400 MHz NMR spectrometer, SAIF, Punjab University, Punjab. 
 
 
 The  Mass  spectra  of  the  synthesized  compounds  are  recorded  in  JEOL 
GCmate using Electron impact method as ionization mode in SAIF, IIT- 
Madras. 
 
   The analgesic activity of the synthesized compounds was screened by Eddy’s 
 
Hot plate method in Adhiparasakthi College of Pharmacy, Melmaruvathur. 
 
 
   The antimicrobial activity of the synthesized compounds was screened  by 
 
Pharma Analytical Lab, Puducherry. 
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Figure-1                        B. SCHEME OF THE WORK 
 
SCHEME I 
 
 
 
 
 
COOH 
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ClCOCH 2 Cl 
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COOH 
 
 
NHCOCH 2 Cl 
 
Anthranilic acid            Chloroacetyl chloride 
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N NH   C     CH   NH BOC 
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QAL = 
QAA = 
 
 
 
 
 
CH2 
 
 
CH3 
 
 
 
 
CH3 
 
CH3 
N         
CH2 Cl 
 
TFA/CHCl 3 
 
1 h 
 
 
O 
O 
N    NH   C      CH 
R 
NH2 
QAPA = CH2 
N        CH2 Cl 
2-Chloromethyl-3-aminoacid substituted quinazolin-4-(3H)-one 
 
QAG =              H 
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Figure-2 
 
 
 
 
 
 
 
COOH 
+ 
NH
2
 
 
 
 
 
 
ClCH
2
 
 
 
 
 
 
COCl 
SCHEME II 
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C. METHADOLOGY 
Procedure for scheme I 
Synthesis of N-chloroacetyl anthranilic acid: 
0.1M (13.7gm) of anthranillic acid was taken in a 250 ml round bottom flask 
followed by addition  of 0.15M (16.95ml)  chloroacetyl chloride in 80ml of benzene 
and two to three drops of pyridine under cold condition. The reaction mixture is 
refluxed for 6 h cooled and filtered it.   The solid was purified by recrystallization 
from   acetone-ethanol   mixture  (1:1).   (  Shashikant   R   Pattan.,     et  al.,   2006) 
 
 
COOH 
 
 
NH2 
6 h 
+     ClCOCH2Cl 
COOH 
 
 
NHCOCH2Cl 
 
Anthranillic acid Chloroacetyl chloride N-Chloroacetyl anthranilic acid 
 
 
Synthesis of 3-amino-2-(chloromethyl) quinazolin-4(3H)-one): 
 
 
N-Chloroacetyl anthranilic acid (0.01M) was refluxed with Hydrazine hydrate 
(0.01M) in the presence of 10g of K2CO3  in 100ml of dry ethanol for 16 h.   The 
ethanol was evaporated and the mixture was neutralized with 0.1M HCl under ice 
cold  condition.  Then  the residue was  washed  thoroughly with  boiling  water and 
recrystallized from acetone: ethanol mixture (1:1).   ( Shashikant R Pattan.,   et al., 
2006) 
 
 
 
COOH 
16 h                     O 
 
Ethanol 
+     NH2NH2.H2O                                          
N
 
NH2 
NHCOCH2Cl N       CH2Cl 
 
N-Chloroacetyl anthranilic acid Hydrazine hydrate 3-amino-2-(chloromethyl)  quinazolin-4(3H)-
one) 
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Protection of Amino Group 
 
 
The amino acid (20 m.mol) was dissolved in a mixture of 1N NaOH (20 ml) 
and IPA (20 ml). To this BOC (26 m.mol, 6 ml) in IPA (10 ml) was added, followed 
by 1N NaOH (20 ml) to the resulting solution. The solution was stirred at room 
temperature for 2 h, washed with light petroleum ether (40 – 600C) (20 ml), acidified 
to pH-3 with 2N sulphuric acid and finally extracted with chloroform (3 x 20 ml). The 
organic  layer  was  dried  over  anhydrous  sodium  sulphate  and  evaporated  under 
pressure to give the BOC-amino acid. The crude product was recrystallized using a 
mixture of chloroform and petroleum ether. (Bodanszky. M., 1984) 
 
Coupling of quinazolone with BOC-amino acid 
 
 
3-amino-2-(chloromethyl) quinazolin-4(3H)-one) (10 m.mol) was dissolved in 
DCM (20 ml). To this triethyl amine (4 ml) was added at 0
°
C and the reaction mixture 
was stirred for 15 minutes. BOC- amino acid (10 m.mol) in chloroform (20 ml) and 
EDC (10 m.mol) were added with stirring. After 8 h the reaction mixture was filtered 
and residue was washed with chloroform (30 ml) and added to the filtrate. The filtrate 
was washed with 5% sodium bicarbonate (20 ml) and saturated sodium chloride (20 
ml) and water. Organic layer was dried over anhydrous sodium sulphate and the 
product was recrystallized by chloroform and petroleum ether.  (Bodanszky. M., 1984) 
 
 
O 
 
N     NH2                            
+  HOOC   CH  NH 
 
 
 
 
BOC 
 
O   
O 
N NH   C 
 
 
 
CH   NH  BOC 
R N       CH2Cl                      R N
 
CH2Cl 
 
3-amino-2-(chloromethyl) quinazolin-4(3H)-one 
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Synthesis of 3-amino acid substituted-2-chloromethyl quinazolin-4(3H)-one 
 
The protected amino acid was dissolved in chloroform (15 ml) and treated 
with trifluro acetic acid (2 m.mol). The solution was stirred at room temperature for 
1h and washed with saturated sodium bicarbonate (5 ml) and the organic layer was 
dried  over  anhydrous  sodium  sulphate  and  concentrated  under  reduced  pressure. 
(Bodanszky. M., 1984) 
 
O                      O                                   TFA/CHCl3                              O                     O 
 
N      NH    C 
 
N       CH2Cl 
 
CH   NH 
 
R 
 
BOC 
1 h                                
N 
 
N 
 
NH    C 
 
 
CH2Cl 
 
CH   NH2 
R 
 
 
Procedure for scheme II 
 
Synthesis of (1H-benzimidazol-2-yl) aniline: 
 
 
 
A mixture of O-phenylene diamine 3.8 g (34 mM) and 4-amino benzoic acid 4.5 g 
(33 mM) were stirred in a syrupy ortho-phosphoric acid (45 ml) at 200º C for 2 h. The 
reaction mixture was cooled and poured on to the crushed ice. The bulky white precipitate 
obtained was stirred in cold water (400ml) and sodium hydroxide solution (5 M) was added 
until the pH 7. The resulting solid was filtered and recrystallized from methanol. (Sreena et 
al., 2009) 
 
 
 
NH2 
o 
200  C 
 
+ 
NH2 
 
HOOC            
2 h 
NH2 
N 
NH2 
N 
H 
O-phenylene diamine 4-amino benzoic acid 4-(1H-benzimidazol-2-yl) aniline 
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Synthesis of 4-(5-nitro-1H-benzimidazol-2-yl) aniline: 
 
Concentrated nitric acid (7.5 ml) was placed in 3-necked round bottom flask 
fitted with a mechanical stirrer.  The flask was immersed in ice cold water and added 
slowly concentrated sulphuric acid (7.5 ml) down the condenser with slow stirring. 
After the addition, (1H-benzimidazol-2-yl) aniline 5.85 g (0.028 M) was added in a 
portion over a period of 1 h at such a rate that the temperature did not exceed 35º C. 
After continuous stirring for 12 h, the reaction mixture was poured very slowly over 
crushed ice with vigorous stirring.   The formed product was filtered, washed with 
cold water and recrystallized from ethanol. (Jitender Singh et al., 2010) 
 
N 
NH2 
N 
H 
HNO3/H2SO4 O2N 
 
N 
            NH2 
N 
H 
4-(1H-benzimidazol-2-yl) aniline                                    4-(5-nitro-1H-benzimidazol-2-yl) aniline 
 
 
2-chloromethyl-3- substituted quinazolin-4(3H)-one: 
 
 
N-chloroacetyl  anthranilic  acid  (0.01M)  was  refluxed  with  (0.01M)  of  2- 
amino benzthiazole, 2- amino benzimidazole, 2-amino 5-nitro phenyl benzimidazole, 
2-amino 5-nitro pyridine and 2-amino 5-bromo pyridine in the presence of 10g of 
K2CO3 in 100ml of dry ethanol.   The ethanol was evaporated and the mixture was 
neutralized with 0.1M HCl under ice cold condition. Then the residue was washed 
thoroughly with boiling water and recrystallized from acetone: ethanol mixture (1:1). 
 
 
 
 
 
COOH 
+ 
 
NHCOCH2Cl 
 
 
 
 
 
H2N-Ar 
K2CO3 
ethanol 
16 h 
 
O 
Ar 
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N        CH2Cl 
 
 
N-chloroacetyl anthranilic acid 2-chloromethyl-3-substituted quinazolin-4(3H)-one 
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D. EVALUATION OF ANALGESIC ACTIVITY 
 
 
 
The drug is reflected to obligate opioid analgesic activity if it relieves pain by 
acting centrally to elevate pain threshold without disturbing consciousness. If it is 
peripherally acting analgesics, it inhibits prostaglandin synthesis and raises the 
threshold to pain perception. Numerous methods for evaluation of analgesic activity 
are available. They can be categorized into chemical, electrical, mechanical and 
thermal methods. (Gupta S .K., 2004 ) 
 
Chemical Method: Writhing Test, Randall - Selitto Test and Intra Arterial Bradykinin 
 
Test. 
 
 
Electrical Method: Electrical Stimulation of the Tail, Flinch Jump test in Mice and 
 
Tooth Pulp Stimulation in Rabbits 
 
 
Mechanical Method: Haffner’s Tail-clip test in Mice 
Thermal Method: Radiant Heat Method, Tail-Immersion Test and Hot plate Method. 
The thermal method was followed to screen the analgesic activity. In this method the 
 
pain is induced by heat from Eddy’s Hot plate. 
 
 
Standard Drug for Analgesic Activity 
 
 
To screen and compare the analgesic activity of synthesized compounds, the 
pentazocine was used as a standard drug. 
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Standard drug 
 
 
 
 
HO 
 
 
 
 
 
H3C N 
CH3 
CH3 
 
CH3 
 
 
Pentazocine 
 
 
Pentazocine is the one of the potent opioid analgesic. It relieves moderate to 
severe pain by acting centrally to elevate pain threshold without disturbing 
consciousness. 
 
Procedure for Eddy’s Hot Plate Method 
 
Albino mice of either sex (20 - 25g) were grouped as control, standard and test 
(I-II) containing three numbers. The animals were acclimated to laboratory conditions 
for one week prior to the experiment. Eddy’s hot plate with the temperature of 55° ± 
1°C used for the study. Mice were placed on hot plate and the reaction time that is 
licking of paw or jumping response was recorded in seconds.  The cut off time is 15 
seconds and the animals not showing any response after 15 seconds were removed 
from the study.  The test compounds were administered intraperitonially with a dose 
of 50 mg/kg in 1% polyethylene glycol. Standard group was administered with 
pentazocine intraperitonially in a dose of 50mg/kg whereas the control group was 
given only with 1% v/v polyethylene glycol. The reaction time was measured at the 
interval of 0, 30, 60, 90 and 180 min. The animal study protocol was approved by 
IAEC (Reg No: 409/01/CPCSEA). The results are reported in Table No. (Eddy N. B., 
et al., 1953) 
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E. EVALUATION OF ANTIBACTERIAL ACTIVITY 
 
 
 
The antibacterial activity can be evaluated by the following techniques. 
 
 
A) Agar streak dilution method 
 
B)  Serial dilution method 
 
C) Agar diffusion method 
 
Cup plate method 
Cylinder method 
Paper disc method 
D) Disc diffusion method 
 
The antibacterial activity of synthesized compounds were screened in the 
concentration of 25, 50 and 100 μg in dimethyl formamide against gram positive 
organism Staphylococcus aureus and gram negative organism Escherichia coli in 
Muller Hinton agar medium by disc diffusion method. The antimicrobial activity was 
evaluated by measuring zone of inhibition in mm, the details of the procedure are 
given below. 
 
Preparation of Muller Hinton Agar 
 
 
Composition 
 
 
Beef extract                            10.0 g 
Casein acid hydrolysis           17.5 g 
Starch                                     1.5 g 
Agar                                        20.0 g 
Distilled water                        1000 ml 
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All the ingredients were taken in 1000 ml of distilled water in a conical flask 
and heated in a steam bath to dissolve. The pH was adjusted to 7.0 ± 0.2 and sterilized 
in autoclave at 15 lb at 120
° 
C for 15 minutes. The sterile medium was poured into 
petridish and allowed to solidify. 
 
Preparation of the Disks 
 
Paper disks of 5 mm diameter and 2 mm thickness were sterilized by 
autoclaving at 121
° 
C for 15 minutes. Ciprofloxacin (10 µ g/ml) was used as standard 
antibiotic for the comparation of antibacterial activity of the synthesized compounds. 
 
Organism used 
 
Gram positive Organisms 
Staphylococcus aureus ATCC 6538P 
Gram negative Organisms 
Escherichia coli ATCC 2592 
Standard drug 
 
O 
 
F                                 COOH 
 
 
N                     N 
 
HN 
 
 
Ciprofloxacin 
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IV. F. EVALUATION OF ANTIFUNGAL ACTIVITY: 
 
The antifungal activity can be evaluated by the following techniques: 
Cup and plate method/ Cylinder method 
Turbidimetry / Tube assay method 
 
Organism used 
 
Aspergillus niger ATCC 9029 
 
The antifungal activity of synthesized compounds was screened in the 
concentration of 25, 50 and100 μg in dimethyl formamide against Aspergillus niger. 
The antifungal activity was evaluated by measuring zone of inhibition in mm, the 
details of the procedure are given below. 
 
Preparation of Sabouraud’s Agar Media 
 
Composition 
 
Dextrose                     20 g 
Peptone                       10 g 
Purified water             1000 ml 
pH                               5.4 ± 0.2 
Agar                            15 g 
 
The  media  was  prepared  by  dissolving  the  specified  quantities  of  the 
dehydrated ingredients (Hi-media) in purified water and was distributed in petridish to 
a thickness of 3-4 mm. The plates were sterilized by autoclaving at 121
° 
C for 15 
minutes. The sterile medium was poured into petridish and allowed to solidify. 
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Standard drug 
 
 
Cl                                                                                 O 
 
 
 
O 
Cl          
N                                  O 
O 
N          CH3 
 
N 
 
N 
 
 
Ketaconazole 
 
 
 
Procedure for Antimicrobial activity 
 
 
The synthesized compounds were tested for antibacterial and antifungal activity by 
disc diffusion method at the concentration of 25, 50 and100 µ g/ml.  Whatmann filter 
paper (grade-1) disc of 5 mm diameter and 2 mm width was sterilized by autoclaving 
for 15 min at 121°C. The sterile agar petridish was seeded with test bacteria and the 
impregnated discs were placed on the medium with suitable space between the discs. 
The plates were incubated at 37°C ± 1°C for 18-24 h for bacterial medium and 25°C ± 
1°C  for  72  h  for  fungal  medium.  The  inhibition  of  zones  caused  by  various 
synthesized compounds and standard drugs ciprofloxacin and ketoconazole on the 
bacterial and fungal microorganisms were examined. 
(Ind. Pharmacopoeia, vol –I, 2007). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESULTs AND 
 
DISCUSSION 
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V. RESULTS AND DISCUSSION 
 
 
 
The  completion  of  reaction  was  monitored  by  TLC  using  silica  gel  as 
stationary phase and chloroform-methanol as mobile phase. The spot in the TLC plate 
was detected by iodine vapours. The chloroform and petroleum ether mixture was 
used to purify the compounds. The satisfactory yield was obtained for every reaction. 
The Physical and spectral data’s of the synthesized compounds are given below 
 
a. Physical data of the compounds 
 
 
i) Physical Data of BOC-Amino acid 
 
 
The amino group of amino acid is protected by tert-butyl oxy carbonic 
anhydride (BOC). The BOC amino acids were obtained with good yield. The Physical 
Data of the BOC-Amino acids are given below. 
Table-2 
 
BOC- 
 
amino acid 
Molecular 
 
formula 
Molecular 
 
weight 
Physical 
 
state 
M. P 
 
(
o
C) 
Yield 
 
(%) 
 
 
 
BOC-Leu 
 
 
 
C11H21NO4 
 
 
 
231.29 
White 
 
powder 
 
 
 
82-85 
 
 
 
42.2 
 
 
 
BOC - Ala 
 
 
 
C8H15NO4 
 
 
 
189.21 
White 
 
powder 
 
 
 
110-113 
 
 
 
62.0 
 
 
 
BOC- Phe 
 
 
 
C14H19NO4 
 
 
 
265.31 
white 
 
powder 
 
 
 
140-142 
 
 
 
72.2 
 
 
 
BOC-Gly 
 
 
 
C7H13NO4 
 
 
 
175.80 
White 
 
powder 
 
 
 
88-90 
 
 
 
26.2 
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ii) Physical Data of 2-chloromethyl-3-amino acid substituted quinazolin-4-(3H)- 
ones 
The BOC protected amino groups are deprotected by using trifluro acetic acid 
in chloroform and the physical data of the compounds are given below 
Table-3 
 
Compound Molecular 
formula 
Molecular 
weight 
Physcial 
 
State 
Yield 
 
(%) 
Rf Value 
QAL C15H9 ClN4O2 322.78 Semisolid 52.12 0.58 
QAA C12 H13ClN4O2 280.71 Semisolid 70.20 0.64 
QAPA C18 H17ClN4O2 356.80 Semisolid 85.00 0.68 
QAG C11 H11ClN4O2 266.68 Semisolid 70.80 0.55 
Solvent system for TLC:- Chloroform : Methanol (7:3) 
 
 
 
iii) Physical Data of 2-chloromethyl-3-heterocyclic substituted quinazolin-4(3H)- 
ones 
Table-4 
 
Compound Molecular 
 
formula 
Molecular 
 
weight 
Physcial 
 
state 
Yield 
 
(%) 
M.P 
 
(°C) 
Rf 
 
Value 
QBEN C16H ClN4SO3 371.50 Brown colour 70.16 286 0.60 
QIBM C16 H11ClN4O 310.00 Brown colour 60.20 194 0.50 
QNIBM C22 H15ClN5O3 432.83 Brown colour 65.00 274 0.80 
QPIN C14 H9ClN4O3 316.70 Brown colour 52.00 254 0.70 
QBrP C14 H9BrClN3O 350.59 Brown colour 46.00 164 0.64 
Solvent system for TLC: - Chloroform: Methanol (7:3) 
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b. Spectral analysis 
 
The synthesized compounds were characterized by IR, proton NMR and Mass 
spectrophotometer  and  the  structures  of  the  compounds  are  consistent  with  the 
spectra. 
IR Spectral Analysis 
 
The IR spectrum was recorded in JASCO FT-IR spectrophotometer. The 
significant IR values are measured in cm
-1 
and the results given in the table. 
 
 
Interpretation of IR spectra of QAL 
 
O                  
O
 
 
 
 
 
CH3 
N    NH   C 
 
N       CH2Cl 
CH 
NH2 
CH2 
 
 
CH3 
 
The significant wave numbers of the compound and its relevant functional 
groups are given below: 
Table-5 
 
 
 
 
S. No 
 
Wave numbers (cm
-1
) 
 
 
Functional groups 
 
 
1 
 
 
3449 
 
 
NH Stretching (NH2) 
 
 
2 
 
 
2959 
 
 
Aromatic –CH- Stretching 
 
 
3 
 
 
1649 
 
 
C=O Stretching in amide 
 
 
4 
 
 
1515 
 
 
C=N Stretching 
 
 
5 
 
 
1368 
 
 
C-N Stretching 
 
 
6 
 
 
771 
 
 
C-Cl Stretching 
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Figure 3: IR Spectra of QAL 
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Interpretation of IR spectra of QAA 
 
 
 
 
O   
O 
N NH   C 
 
N       CH2Cl 
 
 
 
CH 
NH2 
 
 
 
CH3 
 
 
 
 
The significant wave numbers of the compound and its relevant functional 
groups are given below: 
Table-6 
 
 
 
 
 
 
S. No 
 
Wave numbers (cm
-1
) 
 
 
Functional groups 
 
 
1 
 
 
3435 
 
 
NH Stretching (NH2) 
 
 
2 
 
 
2978 
 
 
Aromatic –CH- Stretching 
 
 
3 
 
 
1697 
 
 
C=O Stretching in amide 
 
 
4 
 
 
1585 
 
 
C=N Stretching 
 
 
5 
 
 
1296 
 
 
C-N Stretching 
 
 
6 
 
 
667 
 
 
C-Cl Stretching 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adhiparasakthi college of Pharmacy                                                                Page 41 
  
Synthesis of quinazolones                                                RESULT & DISCUSSION 
 
 
 
 
 
 
 
 
 
Figure 4: IR Spectra of QAA 
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Interpretation of IR spectra of QAPA 
 
 
 
 
O   
O 
N NH   C 
 
N       CH2Cl 
 
 
 
CH 
NH2 
 
 
 
CH2 
 
 
 
 
The significant wave numbers of the compound and its relevant functional 
groups are given below: 
Table-7 
 
 
 
S. No 
 
Wave numbers (cm
-1
) 
 
 
Functional groups 
 
 
1 
 
 
3434 
 
 
NH Stretching (NH2) 
 
 
2 
 
 
1524 
 
 
NH- Stretching 
 
 
3 
 
 
1683 
 
 
C=O Stretching in amide 
 
 
4 
 
 
1524 
 
 
C=N Stretching 
 
 
5 
 
 
1299 
 
 
C-N Stretching 
 
 
6 
 
 
700 
 
 
C-Cl Stretching 
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Figure 5: IR Spectra of QAPA 
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Interpretation of IR spectra of QAG 
 
 
 
 
O   O 
N NH   C 
 
N       CH2Cl 
 
 
 
CH2  NH2 
 
 
 
 
The significant wave numbers of the compound and its relevant functional 
groups are given below: 
Table-8 
 
 
 
S. No 
 
Wave numbers (cm
-1
) 
 
 
Functional groups 
 
 
1 
 
 
3431 
 
 
NH Stretching (NH2) 
 
 
2 
 
 
1524 
 
 
NH- Stretching 
 
 
3 
 
 
1686 
 
 
C=O Stretching in amide 
 
 
4 
 
 
1585 
 
 
C=N Stretching 
 
 
5 
 
 
1289 
 
 
C-N Stretching 
 
 
6 
 
 
771 
 
 
C-Cl Stretching 
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Figure 6: IR Spectra of QAG 
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Interpretation of IR spectra of QBEN 
 
 
 
 
O        N 
 
N         S                NO2 
 
N       CH2Cl 
 
 
 
 
The significant wave numbers of the compound and its relevant functional 
groups are given below: 
Table-9 
 
 
 
S. No 
 
Wave numbers (cm
-1
) 
 
 
Functional groups 
 
 
1 
 
 
3094 
 
 
Aromatic-C-H Stretching 
 
 
2 
 
 
1647 
 
 
C=O Stretching in amide 
 
 
3 
 
 
1570 
 
 
C=N Stretching 
 
 
4 
 
 
1330 
 
 
C-N Stretching 
 
 
5 
 
 
720 
 
 
C-Cl Stretching 
 
 
6 
 
 
616 
 
 
C-S bending 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adhiparasakthi college of Pharmacy                                                                Page 47 
  
Synthesis of quinazolones                                                RESULT & DISCUSSION 
 
 
 
 
 
 
 
 
Figure 7: IR Spectra of QBEN 
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Interpretation of IR spectra of QIBM 
 
 
 
 
O        N 
 
N N 
H 
N       CH2Cl 
 
 
 
 
The significant wave numbers of the compound and its relevant functional 
groups are given below: 
Table-10 
 
 
 
S. No 
 
Wave numbers (cm
-1
) 
 
 
Functional groups 
 
 
1 
 
 
3483 
 
 
N-H Stretching 
 
 
2 
 
 
3132 
 
 
C-H Aromatic stretching 
 
 
3 
 
 
3055 
 
 
Imidazole 
 
 
4 
 
 
1666 
 
 
C=O Stretching in amide 
 
 
5 
 
 
1570 
 
 
C=N Stretching 
 
 
6 
 
 
1566 
 
 
C=C stretching 
 
 
7 
 
 
1313 
 
 
C-N stretching 
 
 
8 
 
 
697 
 
 
C-Cl stretching 
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Figure 8: IR Spectra of QIBM 
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Interpretation of IR spectra of QNIBM 
 
 
 
 
O 
N 
N 
N 
N       CH2Cl            
H
 
NO2 
 
 
 
 
The significant wave numbers of the compound and its relevant functional 
groups are given below: 
Table-11 
 
 
 
S. No 
 
Wave numbers (cm
-1
) 
 
 
Functional groups 
 
 
1 
 
 
3446 
 
 
N-H Stretching 
 
 
2 
 
 
3102 
 
 
C-H Aromatic stretching 
 
 
3 
 
 
1676 
 
 
C=O Stretching in cyclic amide 
 
 
4 
 
 
1646 
 
 
C=C Stretching 
 
 
5 
 
 
1528 
 
 
C=N stretching 
 
 
6 
 
 
1343 
 
 
C-N stretching 
 
 
7 
 
 
758 
 
 
C-Cl stretching 
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Figure 9: IR Spectra of QNIBM 
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Interpretation of IR spectra of QPIN 
 
 
 
 
 
O 
 
N       N 
 
N       CH2Cl 
NO2 
 
 
 
 
The significant wave numbers of the compound and its relevant functional 
groups are given below: 
Table-12 
 
 
 
S. No 
 
Wave numbers (cm
-1
) 
 
 
Functional groups 
 
 
1 
 
 
3102 
 
 
C-H Aromatic stretching 
 
 
2 
 
 
1676 
 
 
C=O Stretching in cyclic amide 
 
 
3 
 
 
1606 
 
 
C=C Stretching 
 
 
4 
 
 
1588 
 
 
C=N stretching 
 
 
5 
 
 
1243 
 
 
C-N stretching 
 
 
6 
 
 
1530 
 
 
NO2 Asymmetrical stretching 
 
 
7 
 
 
752 
 
 
C-Cl stretching 
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Figure 10: IR Spectra of QPIN 
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Interpretation of IR spectra of QBrP 
 
 
 
 
Br 
O 
 
N       N 
 
N       CH2Cl 
 
 
 
 
The significant wave numbers of the compound and its relevant functional 
groups are given below: 
Table-13 
 
 
 
S. No 
 
Wave numbers (cm
-1
) 
 
 
Functional groups 
 
 
1 
 
 
3242 
 
 
C-H Aromatic stretching 
 
 
2 
 
 
1656 
 
 
C=O Stretching in amide 
 
 
3 
 
 
1602 
 
 
C=C Stretching 
 
 
4 
 
 
1586 
 
 
C=N stretching 
 
 
5 
 
 
752 
 
 
C-Cl stretching 
 
 
6 
 
 
650 
 
 
C-Br bending 
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Figure 11: IR Spectra of QBrP 
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ii) NMR Spectral Analysis 
 
 
The proton NMR values were recorded in the BRUKER  400 MHz NMR 
 
spectrophotometer 
 
Interpretation of 
1
H NMR spectra of QAL 
 
O   
O 
N NH   C 
 
N       CH2Cl 
 
 
 
CH 
NH2 
 
 
 
CH2 
 
CH3 
 
 
CH3 
 
 
The δ values with reference to the nature of protons are given below. 
 
Table-14 
 
 
S. No Values in 
ppm 
Nature of protons 
 
 
1 
 
 
8.1 
 
 
Protons of aromatic ring in quinazolone 
 
 
2 
 
 
7.2 
 
 
Protons in Amidic nitrogen 
 
 
3 
 
 
5.3 
 
 
Protons in chloromethyl 
 
 
4 
 
 
1.5 
 
 
Protons of primary amine 
 
 
5 
 
 
0.9 
 
 
Proton of isopropyl group 
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Interpretation of 
1
H NMR spectra of QAA 
 
O                   
O 
 
N    NH   C 
 
N       CH2Cl 
 
CH 
NH2 
 
CH3 
 
 
The δ values with reference to the nature of protons are given below. 
 
Table-15 
 
 
S. No Values in 
ppm 
Nature of protons 
 
 
1 
 
 
8.1 
 
 
Protons of aromatic ring in quinazolone 
 
 
2 
 
 
7.3 
 
 
Protons of Amidic nitrogen 
 
 
3 
 
 
5.4 
 
 
Protons in chlorometheyl 
 
 
4 
 
 
3.6 
 
 
Alkyl proton of methine group 
 
 
5 
 
 
1.9 
 
 
Protons of primary amine 
 
 
6 
 
 
1.3 
 
 
Alkyl proton of methyl group 
 
 
7 
 
 
1.0 
 
 
Proton of isopropyl group 
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Interpretation of 
1
H NMR spectra of QAPA 
 
O   O 
N NH   C 
N       CH2Cl 
 
 
 
CH 
NH2 
 
 
 
CH2 
 
 
The δ values with reference to the nature of protons are given below. 
 
Table-16 
 
S. No Values in 
ppm 
Nature of protons 
 
 
1 
 
 
7.31 
 
 
Protons of aromatic ring in quinazolone 
 
 
2 
 
 
7.18 
 
 
Protons of free phenyl group in 
quinazolone 
 
 
3 
 
 
6.8 
 
 
Protons of amidic nitrogen 
 
 
4 
 
 
5.1 
 
 
Protons in chlorometheyl 
 
 
5 
 
 
1.7 
 
 
Protons of primary amine 
 
 
6 
 
 
1.3 
 
 
Alkyl proton of methyl group 
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Interpretation of 
1
H NMR spectra of QAG 
 
O                  O 
 
N    NH   C 
 
N       CH2Cl 
CH2   NH2 
 
 
The δ values with reference to the nature of protons are given below. 
 
 
 
 
 
 
 
Table-17 
 
S. No Values in 
ppm 
Nature of protons 
 
 
1 
 
 
8.02 
 
 
Protons of amidic nitrogen 
 
 
2 
 
 
7.4 
 
 
Protons of aromatic ring in quinazolone 
 
 
3 
 
 
4.1-4.4 
 
 
Protons in chlorometheyl 
 
 
4 
 
 
3.8 
 
 
proton of methyl group 
 
 
5 
 
 
1.5 
 
 
Protons of primary amine 
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Figure 27: NMR Spectra of QAG 
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Interpretation of 
1
H NMR spectra of QBEN 
 
 
O        N 
 
N         S                NO2 
 
N       CH2Cl 
 
 
 
 
 
 
 
 
The δ values with reference to the nature of protons are given below. 
 
Table-18 
 
S. No Values in 
ppm 
Nature of protons 
 
 
1 
 
 
8.0 – 8.1 
 
 
Protons of aromatic ring in benzthiazole 
 
 
2 
 
 
7.4 – 7.7 
 
 
Protons of aromatic ring in quinazolone 
 
 
3 
 
 
4.0 
 
 
Protons in chloromethyl 
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Figure 28: NMR Spectra of QBEN 
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Figure 29: NMR Spectra of QBEN 
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Figure 30: NMR Spectra of QBEN 
  
Synthesis of quinazolones                                                RESULT & DISCUSSION 
 
 
 
 
Interpretation of 
1
H NMR spectra of QIBM 
 
 
O        N 
 
N N 
H 
N 
CH2Cl 
 
 
 
 
 
 
 
 
 
 
The δ values with reference to the nature of protons are given below. 
 
Table-19 
 
S. No Values in 
ppm 
Nature of protons 
 
 
1 
 
 
7.8 
 
 
Protons of aromatic ring in quinazolone 
 
 
2 
 
 
7.1 
Protons of aromatic ring in 
 
Benzimidazole 
 
 
3 
 
 
5.2 
 
 
Protons in chlorometheyl 
 
 
4 
 
 
5.0 
 
 
Protons of secondary amine 
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Figure 31: NMR Spectra of QIBM 
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Figure 32: NMR Spectra of QIBM 
  
Synthesis of quinazolones                                                RESULT & DISCUSSION 
 
 
 
 
Interpretation of 
1
H NMR spectra of QNIBM 
 
O 
N 
N 
N 
N       CH2Cl            
H
 
NO2 
 
 
 
 
 
 
 
 
The δ values with reference to the nature of protons are given below. 
 
Table-20 
 
S. No Values in 
ppm 
Nature of protons 
 
 
1 
 
 
8.1 
 
 
Protons of aromatic ring in quinazolone 
 
 
2 
 
 
7.3–7.8 
 
 
Protons in phenyl group 
 
 
3 
 
 
7.0 
Protons of aromatic ring in 
 
Benzimidazole 
 
 
4 
 
 
4.1-4.3 
 
 
Protons in chlorometheyl 
 
 
5 
 
 
5.0 
 
 
Protons of secondary amine 
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Figure 33: NMR Spectra of QNIBM 
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Figure 35: NMR Spectra of QNIBM 
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Figure 36: NMR Spectra of QNIBM 
  
Synthesis of quinazolones                                                RESULT & DISCUSSION 
 
 
 
 
Interpretation of 
1
H NMR spectra of QPIN 
 
 
O 
 
N        N 
 
N       CH2Cl 
NO2 
 
 
 
 
 
 
 
 
The δ values with reference to the nature of protons are given below. 
 
Table-21 
 
S. No Values in 
ppm 
Nature of protons 
 1 8.5 Protons of aromatic ring in pyridine 
 
 
2 
 
 
7.7-8.1 
 
 
Protons of aromatic ring in quinazolone 
 
 
3 
 
 
4.1-4.4 
 
 
Protons in chloromethyl 
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Figure 37: NMR Spectra of QPIN 
Synthesis of quinazolones RESULT & DISCUSSION 
Adhiparasakthi college of Pharmacy Page 91 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 38: NMR Spectra of QPIN 
  
Synthesis of quinazolones                                                RESULT & DISCUSSION 
 
 
 
 
Interpretation of 
1
H NMR spectra of QBrP 
 
Br 
O 
 
N        N 
 
N       CH2Cl 
 
 
 
 
 
 
 
 
The δ values with reference to the nature of protons are given below. 
 
Table-22 
 
S. No Values in 
ppm 
Nature of protons 
 1 8.6 Protons of aromatic ring in pyridine 
 
 
2 
 
 
8.1 
 
 
Protons of aromatic ring in quinazolone 
 
 
3 
 
 
4.1-4.4 
 
 
Protons in chloromethyl 
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Figure 42: NMR Spectra of QBrP 
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iii) Mass Spectral Analysis 
 
 
Mass spectrum of the sample was recorded in JEOL GCmate by Electron 
impact method as ionization mode. 
 
Interpretation of Mass spectra of QAL 
 
 
O   
O 
N NH   C 
 
N       CH2Cl 
 
 
 
CH 
NH2 
 
 
 
CH2 
 
CH3 
 
 
CH3 
 
 
Molecular Weight: 322.78                                  Molecular Ion Peak: 322.78 
 
 
The possible fragments of the molecule with the relevant to its m/z values are: 
 
 
Table-23 
 
 
S. No m/z Fragments 
1 309.52 O                  O                         CH3 
N    NH   C     CH   CH2 
N                          
NH2 
CH2Cl 
2 281.70 O                  O 
 
N    NH   C     CH   CH3 
N                          
NH2 
CH2Cl 
3 252.61 O                  O 
 
N    NH   C     CH3 
 
N       CH2Cl 
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Figure 43: Mass Spectra of QAL 
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Interpretation of Mass spectra of QAA 
 
 
O 
O 
N    NH   C 
 
N       CH2Cl 
 
 
 
CH CH3 
NH2 
 
 
Molecular Weight: 280.71                                  Molecular Ion Peak: 280.71 
 
 
The possible fragments of the molecule with the relevant to its m/z values are: 
 
Table-24 
 
S. No m/z Fragments 
1 251.62 O 
O 
N    NH   C     CH3 
 
N       CH2Cl 
2 218.62 O 
 
N    NH2 
 
N       CH2Cl 
3 184.71 O 
 
N    NH2 
 
N       CH3 
 
 
4 
 
 
148 
O 
 
NH 
N 
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Figure 44: Mass Spectra of QAA 
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Interpretation of Mass spectra of QAPA 
 
 
O   
O 
N NH   C 
 
N       CH2Cl 
 
 
 
CH 
NH2 
 
 
 
CH2 
 
 
Molecular Weight: 356.80                                  Molecular Ion Peak: 356.80 
 
 
The possible fragments of the molecule with the relevant to its m/z values are: 
 
Table-25 
 
S. No m/z Fragments 
1 296.73 O                  
O
 
 
N    NH   C     CH   CH2   CH3 
N                          
NH2 
CH2Cl 
2 282.72 O                  
O
 
 
N    NH   C     CH   CH3 
N                          
NH2 
CH2Cl 
3 253.16 O                  
O
 
 
N    NH   C     CH2 
N                          
NH2 
CH2Cl 
 
 
4 
 
 
208.69 
O 
 
N    NH2 
 
N       CH2Cl 
5 122.63  
NH 
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Figure 45: Mass Spectra of QAPA 
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Interpretation of Mass spectra of QAG 
 
 
O   O 
N NH   C 
N       CH2Cl 
 
 
 
CH2   NH2 
 
 
Molecular Weight: 266.34                                  Molecular Ion Peak: 266.68 
 
 
The possible fragments of the molecule with the relevant to its m/z values are: 
 
Table-26 
 
S. No m/z Fragments 
1 253.56 O 
 
N    NH   CH2    CH2 
N       CH Cl           
NH2 
2 
2 236.55 O 
 
N    NH   CH2    CH3 
 
N       CH2Cl 
3 208.62 O 
 
N    NH2 
 
N       CH2Cl 
 
 
4 
 
 
194.61 
O 
 
NH 
 
N       CH2Cl 
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Figure 46: Mass Spectra of QAG 
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Interpretation of Mass spectra of QBEN 
 
 
 
O        N 
 
N         S                NO2 
 
N       CH2Cl 
 
 
Molecular Weight: 325.87                                  Molecular Ion Peak: 325.41 
 
 
The possible fragments of the molecule with the relevant to its m/z values are: 
 
Table-27 
 
S. No m/z Fragments 
1 275.3 
 
O        N 
 
N         S 
 
N       CH2Cl 
2 141.4 O 
NH 
N 
3 133.5  
N 
 
S 
 
 
4 
 
 
 119.4 
O 
NH 
N 
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Figure 47: Mass Spectra of QBEN 
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Interpretation of Mass spectra of QIBM 
 
 
 
O        N 
 
N N 
H 
N       CH2Cl 
 
 
Molecular Weight: 274.27                                  Molecular Ion Peak: 274.36 
 
 
The possible fragments of the molecule with the relevant to its m/z values are: 
 
Table-28 
 
S. No m/z Fragments 
1 261 
 
O        N 
 
N N 
H 
N       CH3 
2 236 O        N 
 
N N 
H 
N 
3 145 O 
NH 
N 
 
 
4 
 
 
  117 
 
NH2 
 
N 
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Figure 48: Mass Spectra of QIBM 
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Interpretation of Mass spectra of QNIBM 
 
 
O 
N 
N 
N 
N       CH2Cl            
H
 
NO2 
 
 
Molecular Weight: 432.31                                  Molecular Ion Peak: 432.83 
 
 
The possible fragments of the molecule with the relevant to its m/z values are: 
 
Table-29 
 
S. No m/z Fragments 
1 389.5 O 
N 
N 
N 
N       CH2Cl            
H
 
2 350.78 O 
N 
N 
N 
N       CH2Cl            
H
 
3 312.74 O 
N 
N 
 
N       CH2Cl 
 
 
4 
284.72 O 
 
N 
 
N       CH2Cl 
5 210.66 O 
 
N 
 
N       CH2Cl 
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Figure 49: Mass Spectra of QNIBM 
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Interpretation of Mass spectra of QPIN 
 
 
 
O 
 
N        N 
 
N       CH2Cl 
NO2 
 
 
Molecular Weight: 316.45                                  Molecular Ion Peak: 316.59 
 
 
The possible fragments of the molecule with the relevant to its m/z values are: 
 
Table-30 
 
S. No m/z Fragments 
1 268.22 O                          NO2 
 
N 
N 
N 
2 257.24 O                          NO2 
 
N 
 
N 
3 218.25 NO2 
 
NH 
 
 
4 
173.25  
 
NH 
5 107.15  
NH2 
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Figure 50: Mass Spectra of QPIN 
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Interpretation of Mass spectra of QBrP 
 
 
Br 
O 
 
N       N 
 
N       CH2Cl 
 
 
Molecular Weight: 350.57                                  Molecular Ion Peak: 350.59 
 
 
The possible fragments of the molecule with the relevant to its m/z values are: 
 
Table-31 
 
S. No m/z Fragments 
1 318 O                          Br 
 
N 
N 
N       CH3 
2 306 O                          Br 
 
N 
 
N       CH3 
3 296 O                          Br 
 
N 
 
 
CH3 
 
 
4 
253 O                          Br 
 
NH 
5 236 Br 
 
NH 
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Figure 51: Mass Spectra of QBrP 
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Evaluation of analgesic activity 
 
 
The analgesic activity of the synthesized compounds was evaluated by Eddy’s 
 
hot plate method in mice with reference to the standard drug pentazocine. 
 
 
Table-32.  Results of Analgesic activity 
 
Compound Paw licking or jumping response (in sec) 
0 min 30 mins 60 mins 90 mins 180 mins 
Control  
7.02 ±0.58 
 
8.06 ±0.58 
 
7.08 ±0.58 
 
7.01 ±0.58 
 
6.67 ±0.67 
Standard 
 
(50mg/kg) 
 
 
 
 
10.04±1.15 
 
 
 
 
11.03 ±0.58 
 
 
 
 
10.21 ±0.58 
 
 
 
 
9.67 ±0.33 
 
 
 
 
8.27 ±0.88 
QAPA 
(50mg/kg) 
 
 
 
 
7.02 ±0.78 
 
 
 
 
9.76±0.32** 
 
 
 
 
8.88±0.58** 
 
 
 
 
8.78 ±0.78* 
 
 
 
 
6.08±0.98 
QIBM 
(50mg/kg) 
 
 
 
 
8.06 ±0.58 
 
 
 
 
9.33 ±0.33 
 
 
 
 
9.73 ±0.33* 
 
 
 
 
7.02±0.58 
 
 
 
 
6.33 ±0.31 
 
 
*P<0.05, **P<0.01. ***P<0.001 compare to 0 h response. One-way ANOVA 
followed by Bonferroni test. 
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Screening of antimicrobial activity 
i)  Antibacterial Activity 
The antibacterial activity of synthesized compounds were screened against 
both gram positive (S. aureus) and gram negative (E. coli) organism by agar disc 
diffusion method using ciprofloxacin as standard drug. 
 
Table-33.  Results of Antibacterial Activity 
 
 
 
 
 
Compounds 
Zone of Inhibition (in mm) 
 
 
S. aureus 
 
 
E. coli 
25 
(µg/ml) 
50 
(µg/ml) 
100 
(µg/ml) 
25 
(µg/ml) 
50 
(µg/ml) 
100 
(µg/ml) 
QAL 22 26 31 11 14 20 
QAA 19 22 26 19 22 24 
QAPA 15 19 23 21 24 29 
QAG 14 19 22 18 21 26 
QBEN 15 18 27 20 23 29 
QIBM 19 21 27 16 21 27 
QNIBM 16 19 29 17 22 28 
QPIN 22 26 28 20 22 28 
QBrP 20 22 28 15 18 24 
Ciprofloxacin 
 
10(µg/ml) 
39 38 
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. 
 
 
 
Figure 52: Antimicrobial activity of synthesized compounds against S.aureus 
Adhiparasakthi college of Pharmacy Page 118 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 53: Antimicrobial activity of synthesized compounds against E.coli 
Adhiparasakthi college of Pharmacy Page 119 
 
 
 
 
 
 
 
ii)  Antifungal Activity 
 
 
The antifungal  activities  of synthesized  compounds  were  screened  against 
 
A.niger by agar disc diffusion method using ketoconazole as standard drug. 
 
 
Table-34.  Results of Antifungal activity 
 
 
 
 
 
Compounds 
Zone of Inhibition (in mm) 
Aspergillus niger 
25 
(µg/ml) 
50 
(µg/ml) 
100 
(µg/ml) 
QAL 22 26 31 
QAA 19 22 26 
QAPA 15 19 23 
QAG 14 19 22 
QBEN 15 19 23 
QIBM 13 16 18 
QNIBM 21 24 29 
QPIN 22 26 28 
QBrP 15 13 24 
Ketoconazole 
 
 
10(µg/ml) 
39 
Adhiparasakthi college of Pharmacy Page 120 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 54: Antimicrobial activity of synthesized compounds against A.niger 
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DISCUSSION 
 
 
Analgesic activity: 
 
The synthesized compounds were tested for their Analgesic activity by Eddy’s 
hot plate method where the source of pain is heat and the results of the compounds 
were compared with the standard drug pentazocine. The activity was observed up to 
180 minutes. 
 
 
The  standard  drug  pentazocine  showed  increase  in  reaction  time  to  the 
stimulus with maximum response at 60
th  
minute. Also at 60
th  
minute, both QAPA 
and QIBM were found to be significant compared to control. The activity was started 
to abolish gradually after 60
th  
min. One-way ANOVA followed by Bonferroni test 
was applied to the results to find the results are statistically significant or not in the 
used population. 
 
Antimicrobial activity 
 
 
The antimicrobial activity was screened disc diffusion method were Muller 
Hinton Agar media used for bacteria and Sabouraud’s agar media used for fungal 
growth. 
Antibacterial activity 
 
Among the compounds used for antibacterial activity, QPIN, QNIBM, QBEN 
could show significant activity against both (S. aureus) and (E. coli) organisms. The 
QAL and QAA were somewhat selective for the inhibition of gram positive organism 
(S. aureus). The rest of the compounds could show only moderate activity at the 
optimal concentration of 100µ g/ml when compared to 10µ g/ml of ciprofloxacin as 
standard. 
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Antifungal activity 
 
Among the compounds QAL, QNIBM and QPIN shown good antifungal 
activity against A. niger and rest of the compounds could show only moderate activity 
at  the  maximum  concentration  of  100µ g/ml  when  compared  to  10µ g/ml  of 
ketoconazole as standard. 
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VI. SUMMARY 
 
 
Totally nine compounds of newly modified quinazolin-4 (3H)-ones were synthesize 
Four  derivatives  of  quinazolones  were  synthesized  by incorporating  the  amino  acids  of 
Leucine, alanine, phenylalanine and glycine at third position of the ring. Anthranilic acid was 
treated with chloracetyl chloride and obtained N-chloro acetyl anthranilic acid.  To synthesize 
amino acid incorporated quinazolones, the N-chloroacetyl anthranilic acid was treated with 
hydrazine hydrate and derived 3-amino-2-chloromethyl quinazolin-4(3H)-one. Then this 
intermediate was coupled with protected amino acids, using EDC as coupling agent. Finally 
the BOC was deprotected to have 2-chloromethyl-3-amino acid substituted quinazolin-4(3H)- 
ones. 
Five derivatives of quinazolones were synthesize by incorporating the heterocyclic 
moieties of substituted Indole, Benzthiazole and Pyridine at third position of the ring. 
Anthranilic acid was treated with chloroacetyl chloride and obtained N-chloro acetyl 
anthranilic acid. To synthesize heterocyclic incorporated quinazolones, N-Chloroacetyl 
anthranilic acid was refluxed separately with  2-amino benzthiazole, 2- amino benzimidazole, 
2-amino  5-nitro  phenyl  benzimidazole,  2-amino  5-nitro  pyridine  and  2-amino  5-bromo 
pyridine and resulting 2-chloromethyl-3-heterocycle substituted quinazolin-4(3H)-one. 
The completion of the reaction was checked by TLC. The chloroform and petroleum 
ether mixture was used for the purification of the amino acid derivatives of quinazolinones 
and the heterocylic derivatives of quinazolinones was washed thoroughly with boiling water 
and recrystallized from acetone: ethanol mixture (1:1). 
The structures of the synthesize compounds were confirmed with IR, 
1
H NMR and 
 
Mass spectroscopy. 
Synthesis of quinazolinones SUMMARY 
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The synthesize compounds were tested for their analgesic activity by Eddy’s hot 
plate  method  where  the  source  of  pain  is  heat  and  the  results  of  the  compounds  were 
compared with the standard drug pentazocine. One-way ANOVA followed by Bonferroni test 
was applied to the results to find the results are statistically or not in the used population. 
 
The synthesize compounds were screened for their antimicrobial activity for the gram 
positive, gram negative and fungal organism by disc diffusion method and the inhibition of 
microorganism were compared with the standard drugs ciprofloxacin and ketoconazole 
respectively. 
The compounds QAPA, QIBM shown moderate analgesic activity. 
 
The compounds QAL, QAA, QBEN, QNIBM and QPIN were shown significant 
activity against the organism used for the study. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONCLUSION 
Synthesis of quinazolinones CONCLUSION 
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VII. CONCLUSION 
 
 
 
The two different set of quinazolones containing amino acids and heterocycles 
separately were synthesize and evaluated.  The analgesic and antimicrobial activities 
are not very significant for one set of compounds than the other.   Though all the 
compounds shown biological action it is better to incorporate the dipeptides and other 
heterocycles. 
 
For the amino acid series the rationale cannot be drawn for the different amino 
acids used, since the aliphatic amino acid leucine and alanine activity is equal to 
aromatic amino acid phenyl alanine.  There is no distinct difference in the biological 
action upon increasing the hydrophobicity through increasing number of carbons. 
May be the di or tripeptide incorporation at the 3
rd  
position can give an idea about 
whether the amino acid/peptides incorporation in the quinazolones may overtake the 
heterocycles or not. 
 
For   heterocyclic   incorporate   series,   among   the   Benzimidazole   and 
Benzthiazole and pyridine used, the nitro group substituted compounds are active than 
others. May be the electron withdrawing group are required to enhance the biological 
action of the quinazolones. 
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annexure 
SYNTHESIS OF QUINAZOLONE ANNEXURE I 
 
 
 
 
 
ANNEXURE I 
The animal study protocol was approved by IAEC (Reg No: 409/01/CPCSEA). 
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